Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPOR | P19235 | 3/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.41 |
| ▸ | ECE1 | P42892 | 1/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.41 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.40 |
| ▸ | TPSD1 | Q9BZJ3 | 2/20 | 0.40 |
| ▸ | TPSG1 | Q9NRR2 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22804052 | 0.95 | EPOR (0.51) | EPORFOLH1LTA4HITGB3ITGA2B | |
| SCHEMBL1491987 | 0.95 | EPOR (0.51) | EPORFOLH1LTA4HITGB3ITGA2B | |
| SCHEMBL3776750 | 0.95 | EPOR (0.51) | EPORFOLH1LTA4HITGB3ITGA2B | |
| SCHEMBL9574165 | 0.91 | EPOR (0.46) | EPORFOLH1ITGB3ITGA2BTPSAB1 | |
| SCHEMBL10477497 | 0.91 | EPOR (0.46) | EPORFOLH1ITGB3ITGA2BTPSAB1 | |
| SCHEMBL4852056 | 0.91 | EPOR (0.46) | EPORFOLH1ITGB3ITGA2BTPSAB1 | |
| SCHEMBL5383813 | 0.87 | EPOR (0.45) | EPORFOLH1LTA4HITGB3ITGA2B | |
| SCHEMBL9197438 | 0.87 | EPOR (0.45) | EPORFOLH1LTA4HITGB3ITGA2B | |
| SCHEMBL4790017 | 0.87 | EPOR (0.45) | EPORFOLH1LTA4HITGB3ITGA2B | |
| SCHEMBL28836234 | 0.87 | EPOR (0.50) | EPORFOLH1LTA4HITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112029092-A | Cinnamic aldehyde modified polyethylene glycol-polyamino acid block copolymer, preparation method thereof and hydrogel | 中国科学院长春应用化学研究所 | 2020-12-04 | — | — | CN | claimed |
| CN-112029092-A | Cinnamic aldehyde modified polyethylene glycol-polyamino acid block copolymer, preparation method thereof and hydrogel | 中国科学院长春应用化学研究所 | 2020-12-04 | — | — | CN | disclosed |
| US-20100092416-A1 | METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS | L'OREAL S.A. (FR) | 2010-04-15 | — | — | US | disclosed |
| US-20100061953-A1 | METHOD FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS AND COMPOSITION CONTAINING A GRAFTED AMINO ACID POLYMER | L'OREAL S.A. (FR) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100061953-A1 | METHOD FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS AND COMPOSITION CONTAINING A GRAFTED AMINO ACID POLYMER | KRT18, CUTA, AADAT | EPOR 4383/4885FOLH1 243/4885LTA4H 1988/4885 |
| US-20100092416-A1 | METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS | KRT18, CUTA, OAT | EPOR 3643/4885FOLH1 812/4885LTA4H 1677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.